Two Sigma Investments, LP Immunovant, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$30.27 - $43.79 $2.2 Million - $3.19 Million	-72,768 Reduced 92.0%	6,331 $204,000
Q4 2023 Feb 14, 2024	SELL	$31.31 - $44.19 $8.37 Million - $11.8 Million	-267,297 Reduced 77.17%	79,099 $3.33 Million
Q3 2023 Nov 14, 2023	SELL	$18.55 - $39.96 $12.3 Million - $26.5 Million	-663,087 Reduced 65.69%	346,396 $13.3 Million
Q2 2023 Aug 14, 2023	BUY	$14.2 - $23.75 $519,904 - $869,558	36,613 Added 3.76%	1,009,483 $19.1 Million
Q1 2023 May 15, 2023	BUY	$15.27 - $19.72 $9.4 Million - $12.1 Million	615,833 Added 172.48%	972,870 $15.1 Million
Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $648,917 - $1.75 Million	98,470 Added 38.08%	357,037 $6.34 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $6.37 $1.15 Million - $1.86 Million	-291,816 Reduced 53.02%	258,567 $1.44 Million
Q2 2022 Aug 15, 2022	SELL	$3.38 - $5.65 $917,622 - $1.53 Million	-271,486 Reduced 33.03%	550,383 $2.15 Million
Q1 2022 May 16, 2022	SELL	$5.06 - $8.77 $160,194 - $277,649	-31,659 Reduced 3.71%	821,869 $4.53 Million
Q4 2021 Feb 14, 2022	SELL	$7.33 - $9.32 $2.13 Million - $2.71 Million	-290,783 Reduced 25.41%	853,528 $7.27 Million
Q3 2021 Nov 15, 2021	SELL	$7.01 - $11.37 $917,174 - $1.49 Million	-130,838 Reduced 10.26%	1,144,311 $9.94 Million
Q2 2021 Aug 16, 2021	BUY	$9.4 - $16.85 $4.74 Million - $8.5 Million	504,584 Added 65.48%	1,275,149 $13.5 Million
Q1 2021 May 17, 2021	BUY	$13.08 - $49.6 $9.65 Million - $36.6 Million	737,829 Added 2253.88%	770,565 $12.4 Million
Q4 2020 Feb 16, 2021	SELL	$36.36 - $52.71 $1 Million - $1.46 Million	-27,609 Reduced 45.75%	32,736 $1.51 Million
Q3 2020 Nov 16, 2020	BUY	$22.61 - $38.9 $1.16 Million - $1.99 Million	51,198 Added 559.72%	60,345 $2.12 Million
Q2 2020 Aug 14, 2020	BUY	$13.87 - $28.44 $126,868 - $260,140	9,147 New	9,147 $223,000

Others Institutions Holding IMVT

# of Institutions

212

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

Vanguard Group Inc Valley Forge, PA

6.66M
Shares

$183 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.92M
Shares

$135 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.35M
Shares

$120 Million
4.41% of portfolio
Armistice Capital, LLC New York, NY

3.55M
Shares

$97.6 Million
1.62% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

3.33M
Shares

$91.6 Million
0.06% of portfolio

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account